Literature DB >> 18023352

Abnormal EMG muscle activity during gait in patients without neurological disorders.

R Brunner1, J Romkes.   

Abstract

Abnormal muscle activity in patients with a central neurological disorder is commonly attributed to the underlying condition. This study considered abnormal muscle activity in orthopaedic patients who had no neurological involvement. Thirty-nine patients with a variety of orthopaedic problems underwent gait analysis, which included measurement of passive range of motion at the legs, manual muscle strength testing (MMST), instrumented gait analysis, and surface electromyography (EMG). Abnormal timing and duration of EMG activity was found in 51/77 legs. Muscle weakness was the most important cause of the abnormal EMG activity (p<0.001). However, abnormal muscle activity did not correspond to the joint which was controlled by the weak muscles. The triceps surae muscle, represented by the medial gastrocnemius, was significantly more involved (68.6%). Co-activity of the knee extensors and hamstrings was found in 17% of the affected legs. Three out of the 51 legs showed a continuous activity of the rectus femoris muscle in swing. These findings illustrate mechanisms to compensate for muscle weakness in stance in neurologically intact subjects.

Entities:  

Mesh:

Year:  2007        PMID: 18023352     DOI: 10.1016/j.gaitpost.2007.05.009

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  10 in total

Review 1.  Biomechanics and muscle function during gait.

Authors:  R Brunner; E Rutz
Journal:  J Child Orthop       Date:  2013-09-15       Impact factor: 1.548

2.  Feedforward neural control of toe walking in humans.

Authors:  Jakob Lorentzen; Maria Willerslev-Olsen; Helle Hüche Larsen; Christian Svane; Christian Forman; Rasmus Frisk; Simon Francis Farmer; Uwe Kersting; Jens Bo Nielsen
Journal:  J Physiol       Date:  2018-04-15       Impact factor: 5.182

3.  Electromyographic characteristics of gait impairment in cervical spondylotic myelopathy.

Authors:  Ailish Malone; Dara Meldrum; John Gleeson; Ciaran Bolger
Journal:  Eur Spine J       Date:  2013-08-02       Impact factor: 3.134

4.  Gait changes following robot-assisted gait training in children with cerebral palsy.

Authors:  D Žarković; M Šorfová; J J Tufano; P Kutílek; S Vítečková; D Ravnik; K Groleger-Sršen; I Cikajlo; J Otáhal
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

Review 5.  [Principles of treatment of spastic palsy in children: a critical review].

Authors:  R Brunner
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.087

6.  Abnormal leg muscle latencies and relationship to dyscoordination and walking disability after stroke.

Authors:  Janis J Daly; Kristen Roenigk; Roger Cheng; Robert L Ruff
Journal:  Rehabil Res Pract       Date:  2010-12-29

7.  Can Lokomat therapy with children and adolescents be improved? An adaptive clinical pilot trial comparing Guidance force, Path control, and FreeD.

Authors:  Tabea Aurich-Schuler; Fabienne Grob; Hubertus J A van Hedel; Rob Labruyère
Journal:  J Neuroeng Rehabil       Date:  2017-07-14       Impact factor: 4.262

8.  Leg surface electromyography patterns in children with neuro-orthopedic disorders walking on a treadmill unassisted and assisted by a robot with and without encouragement.

Authors:  Tabea Aurich Schuler; Roland Müller; Hubertus J A van Hedel
Journal:  J Neuroeng Rehabil       Date:  2013-07-18       Impact factor: 4.262

Review 9.  Plasticity and modular control of locomotor patterns in neurological disorders with motor deficits.

Authors:  Y P Ivanenko; G Cappellini; I A Solopova; A A Grishin; M J Maclellan; R E Poppele; F Lacquaniti
Journal:  Front Comput Neurosci       Date:  2013-09-10       Impact factor: 2.380

10.  Knee osteoarthritis alters peri-articular knee muscle strategies during gait.

Authors:  Aseel Ghazwan; Chris Wilson; Cathy A Holt; Gemma M Whatling
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.